Browsing by Titles

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 7 of 7

Article
DYRK1A modulates fear memory formation via epigenetic modification
  • Kang, Dae-Si ; 
  • Koo, Ja Wook
  • 2025-05
  • Kang, Dae-Si. (2025-05). DYRK1A modulates fear memory formation via epigenetic modification. Molecular Brain, 18(1). doi: 10.1186/s13041-025-01216-8
  • BioMed Central
  • View : 115
  • Download : 0

Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD

Article
Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD
  • Lee, Hyun-Ju ; 
  • Hwang, Jeong-Woo ; 
  • Kim, Jieun ; 
  • Jo, A-Ran ; 
  • Park, Jin-Hee ; 
  • Jeong, Yoo Joo ; 
  • Jang, Ji-Yeong ; 
  • Kim, Su-Jeong ; 
  • Song, Jeong-Heon ; 
  • Hoe, Hyang-Sook
  • 2024-10
  • Lee, Hyun-Ju. (2024-10). Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD. Frontiers in Immunology, 15. doi: 10.3389/fimmu.2024.1421455
  • Frontiers Media
  • View : 335
  • Download : 24
Article
Genetic knockdown of DYRK1A attenuates cognitive impairment, Aβ pathology, tauopathy and neuroinflammatory responses in mouse models of AD
  • Lee, Hyun-ju ; 
  • Kang, Sora ; 
  • Lee, Yoo Jin ; 
  • Oh, Seokjun ; 
  • Joo, Bitna ; 
  • Hwang, Jeong-Woo ; 
  • Kim, Jeongseop ; 
  • Kim, Tae-Eun ; 
  • Jung, Tae-Mi ; 
  • Kim, Yu-Jin ; 
    • et al
  • 2025-11
  • FRONTIERS IN IMMUNOLOGY, v.16
  • FRONTIERS MEDIA SA
  • View : 1
  • Download : 0
Article
Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A
  • Kim, J. ; 
  • Kim, S.-J. ; 
  • Jeong, H.-R. ; 
  • Park, J.-H. ; 
  • Moon, M. ; 
  • Hoe, H.-S.
  • 2022-10
  • Kim, J. (2022-10). Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A. Frontiers in Immunology, 13. doi: 10.3389/fimmu.2022.903309
  • Frontiers Media S.A.
  • View : 362
  • Download : 0
Article
Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β
  • Park, Jin-Hee ; 
  • Hwang, Jeong-Woo ; 
  • Lee, Hyun-ju ; 
  • Jang, Geum Mi ; 
  • Jeong, Yoo Joo ; 
  • Cho, Joonho ; 
  • Seo, Jinsoo ; 
  • Hoe, Hyang-Sook
  • 2023-06
  • Park, Jin-Hee. (2023-06). Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β. Frontiers in Immunology, 14. doi: 10.3389/fimmu.2023.1150940
  • Frontiers Media
  • View : 410
  • Download : 71
Thesis
Lomerizine regulates LPS-induced neuroinflammation and tau phosphorylation in vivo
  • Jinhee Park
  • 2023
  • Jinhee Park. (2023). Lomerizine regulates LPS-induced neuroinflammation and tau phosphorylation in vivo. doi: 10.22677/THESIS.200000687356
  • DGIST
  • View : 267
  • Download : 0
Article
The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation
  • Lee, Hyun-ju ; 
  • Woo, Hanwoong ; 
  • Lee, Ha-Eun ; 
  • Jeon, Hyongjun ; 
  • Ryu, Ka-Young ; 
  • Nam, Jin han ; 
  • Jeon, Seong Gak ; 
  • Park, HyunHee ; 
  • Lee, Ji-Soo ; 
  • Han, Kyung-Min ; 
    • et al
  • 2020-11
  • Lee, Hyun-ju. (2020-11). The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation. doi: 10.1016/j.freeradbiomed.2020.08.030
  • Elsevier Inc.
  • View : 671
  • Download : 0
1